Kathryn Ottolino‐Perry

594 total citations
9 papers, 353 citations indexed

About

Kathryn Ottolino‐Perry is a scholar working on Genetics, Oncology and Biotechnology. According to data from OpenAlex, Kathryn Ottolino‐Perry has authored 9 papers receiving a total of 353 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Genetics, 6 papers in Oncology and 5 papers in Biotechnology. Recurrent topics in Kathryn Ottolino‐Perry's work include Virus-based gene therapy research (7 papers), Cancer Research and Treatments (5 papers) and CAR-T cell therapy research (5 papers). Kathryn Ottolino‐Perry is often cited by papers focused on Virus-based gene therapy research (7 papers), Cancer Research and Treatments (5 papers) and CAR-T cell therapy research (5 papers). Kathryn Ottolino‐Perry collaborates with scholars based in Canada, United States and Finland. Kathryn Ottolino‐Perry's co-authors include J. Andrea McCart, John C. Bell, Brian D. Lichty, Jean‐Simon Diallo, Fernando A. Angarita, Sergio A. Acuña, Nan Tang, J. Andrea McCart, Ralph S. DaCosta and Calvin S.H. Ng and has published in prestigious journals such as Journal of Virology, International Journal of Cancer and Molecular Therapy.

In The Last Decade

Kathryn Ottolino‐Perry

9 papers receiving 346 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kathryn Ottolino‐Perry Canada 8 263 178 105 81 64 9 353
Michael Lanuti United States 8 249 0.9× 115 0.6× 161 1.5× 68 0.8× 67 1.0× 8 371
Hesham Abdelbary Canada 10 298 1.1× 210 1.2× 174 1.7× 42 0.5× 59 0.9× 18 447
Ibrahim Ragab Eissa Japan 8 198 0.8× 190 1.1× 123 1.2× 57 0.7× 38 0.6× 12 307
Adina Pelusio South Korea 5 232 0.9× 233 1.3× 88 0.8× 56 0.7× 45 0.7× 6 331
Benjamin G. Lilienfeld Switzerland 8 401 1.5× 112 0.6× 201 1.9× 24 0.3× 37 0.6× 9 587
Nagarajan Ramesh United States 7 236 0.9× 148 0.8× 186 1.8× 75 0.9× 24 0.4× 9 355
Louise Medley United Kingdom 5 356 1.4× 364 2.0× 197 1.9× 63 0.8× 112 1.8× 10 506
Greg Wolgamot United States 10 199 0.8× 35 0.2× 165 1.6× 12 0.1× 49 0.8× 11 335
Thomas Rothmann Germany 9 307 1.2× 192 1.1× 283 2.7× 93 1.1× 62 1.0× 9 482
Alex Yeung United States 5 178 0.7× 176 1.0× 129 1.2× 66 0.8× 13 0.2× 10 416

Countries citing papers authored by Kathryn Ottolino‐Perry

Since Specialization
Citations

This map shows the geographic impact of Kathryn Ottolino‐Perry's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kathryn Ottolino‐Perry with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kathryn Ottolino‐Perry more than expected).

Fields of papers citing papers by Kathryn Ottolino‐Perry

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kathryn Ottolino‐Perry. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kathryn Ottolino‐Perry. The network helps show where Kathryn Ottolino‐Perry may publish in the future.

Co-authorship network of co-authors of Kathryn Ottolino‐Perry

This figure shows the co-authorship network connecting the top 25 collaborators of Kathryn Ottolino‐Perry. A scholar is included among the top collaborators of Kathryn Ottolino‐Perry based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kathryn Ottolino‐Perry. Kathryn Ottolino‐Perry is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Ottolino‐Perry, Kathryn, Sergio A. Acuña, Fernando A. Angarita, et al.. (2023). Vaccinia virus and peptide-receptor radiotherapy synergize to improve treatment of peritoneal carcinomatosis. Molecular Therapy — Oncolytics. 29. 44–58. 5 indexed citations
2.
Ottolino‐Perry, Kathryn, Kristina M. Blackmore, Liis Lindvere‐Teene, et al.. (2017). Improved detection of clinically relevant wound bacteria using autofluorescence image‐guided sampling in diabetic foot ulcers. International Wound Journal. 14(5). 833–841. 43 indexed citations
3.
Ottolino‐Perry, Kathryn, et al.. (2015). Oncolytic vaccinia virus synergizes with irinotecan in colorectal cancer. Molecular Oncology. 9(8). 1539–1552. 30 indexed citations
4.
Acuña, Sergio A., et al.. (2014). Oncolytic Vaccinia Virus as an Adjuvant Treatment to Cytoreductive Surgery for Malignant Peritoneal Mesothelioma. Annals of Surgical Oncology. 21(7). 2259–2266. 10 indexed citations
5.
Angarita, Fernando A., et al.. (2013). Mounting a strategic offense: fighting tumor vasculature with oncolytic viruses. Trends in Molecular Medicine. 19(6). 378–392. 30 indexed citations
6.
Ottolino‐Perry, Kathryn, Nan Tang, Renee Head, et al.. (2013). Tumor vascularization is critical for oncolytic vaccinia virus treatment of peritoneal carcinomatosis. International Journal of Cancer. 134(3). 717–730. 13 indexed citations
7.
Ottolino‐Perry, Kathryn, et al.. (2010). Antiproliferative Effects of 111 In- or 177 Lu-DOTATOC on Cells Exposed to Low Multiplicity-of-Infection Double-Deleted Vaccinia Virus Encoding Somatostatin Subtype-2 Receptor. Cancer Biotherapy and Radiopharmaceuticals. 25(3). 325–333. 11 indexed citations
8.
Ottolino‐Perry, Kathryn, Jean‐Simon Diallo, Brian D. Lichty, John C. Bell, & J. Andrea McCart. (2009). Intelligent Design: Combination Therapy With Oncolytic Viruses. Molecular Therapy. 18(2). 251–263. 163 indexed citations
9.
Guse, Kilian, Marta Słoniecka, Iulia Diaconu, et al.. (2009). Antiangiogenic Arming of an Oncolytic Vaccinia Virus Enhances Antitumor Efficacy in Renal Cell Cancer Models. Journal of Virology. 84(2). 856–866. 48 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026